arrow
返回
J

June‐Yong Lee

Yonsei University

26H指数
102论文数
4.6K被引数
收录论文 42
发表时间
PDE3B as a multi-organ therapeutic node in the gut–liver axis of metabolic dysfunction-associated steatohepatitisPDE3B作为代谢功能障碍相关脂肪性肝炎肠道-肝脏轴中的多器官治疗节点
err2026-09-01
err0
errOAAI
errYu Seol Lee; Chang-Yun Jeong; Youn Wook Chung; Yoseob Lee; Da Hyun Lee; Ji Yun Bang; Da Ye Kim; Haram Lee; Soohwan Oh; Jinhyuk Bhin; Ji-Hwan Ryu; June-Yong Lee; Soo Han Bae
err分享
err收藏
Intestinal Dysbiosis Caused by Epithelial Fabp6 Gene Disruption Exacerbates Gut Inflammatory Disease由上皮细胞Fabp6基因破坏引起的肠道菌群失调会加剧肠道炎症性疾病
err2025-10-01
err0
errOAAI
errKwon, Kyeongeun; Kim, Minyoung; Jung, Youngrak; Yoon, Mi Young; Lee, June-Yong; Yoon, Sang Sun; Rho, Mina; Chung, Youn Wook; Ryu, Ji-Hwan
err分享
err收藏
Cholesterol sulfate as a negative regulator of cellular cholesterol homeostasis胆固醇硫酸盐作为细胞胆固醇稳态的负调控因子
err2025-06-01
err0
errOAAI
errNam, Le Ba; Kim, Sung-Jin; Nguyen, Tan Khanh; Jeong, Chang-Yun; Lee, June-Yong; Lee, Jun-Seok; Seo, Jeong Taeg; Moon, Seok Jun
err分享
err收藏
err分享
err收藏
Pembrolizumab plus lenvatinib (PL) in recurrent clear cell gynecological cancer (CCGC): Phase II LARA trial (GCGS-OV4/APGOT-OV3)帕博利珠单抗联合仑伐替尼(PL)在复发性透明细胞妇科肿瘤(CCGC)中的疗效:II期LARA试验(GCGS-OV4/APGOT-OV3)
err2024-09-01
err0
PREAI
errNgoi, N.; Lee, J-Y.; Lim, D.; Thian, Y. L.; Lim, Y. W.; Chan, J. J.; Chay, W. Y.; Zhang, Z.; Gopinathan, A.; Lim, S. E.; Low, J.; Ng, J.; Tong, P.; Lee, Y. J.; Park, J.; Kim, J-W.; Zhu, J.; Tai, B. C.; Kim, B-G.; Tan, D. S.
err分享
err收藏
ETV5 promotes lupus pathogenesis and follicular helper T cell differentiation by inducing osteopontin expressionETV5通过诱导骨桥蛋白表达促进狼疮发病和滤泡辅助性T细胞分化
err2024-06-06
err2
PREAI
errPark, Jiho; Lee, Jongeun; Hur, Yunjung; Kim, Chan- Johng; Kim, Han Bit; Um, Dahun; Kim, Da Som; Lee, June - Yong; Park, Sungjun; Park, Youngjae; Kim, Tae- Kyung; Im, Sin- Hyeog; Kim, Sung Won; Kwok, Seung- Ki; Lee, Yoontae
err分享
err收藏
5-aminosalicylic acid suppresses osteoarthritis through the OSCAR-PPARγ axis
err2024-02-03
err2
errOAAI
errKim, Jihee; Ryu, Gina; Seo, Jeongmin; Go, Miyeon; Kim, Gyungmin; Yi, Sol; Kim, Suwon; Lee, Hana; Lee, June-Yong; Kim, Han Sung; Park, Min-Chan; Shin, Dong Hae; Shim, Hyunbo; Kim, Wankyu; Lee, Soo Young
err分享
err收藏
IgSF11 deficiency alleviates osteoarthritis in mice by suppressing early subchondral bone changes
err2023-12-01
err2
errOAAI
errKim, Gyeong Min; Kim, Jihee; Lee, June-Yong; Park, Min-Chan; Lee, Soo Young
err分享
err收藏
Preliminary efficacy of pembrolizumab plus lenvatinib (PL) in recurrent clear cell gynecological cancer (CCGC): Phase II LARA trial (GCGS-OV4/ APGOT-OV3)
err2023-11-01
err0
PREAI
errNgoi, N. Y.; Lee, J-Y.; Lim, Y. W.; Lim, D.; Thian, Y. L.; Gopinathan, A.; Lim, S. E.; Low, J.; Ng, J.; Tong, P.; Zhu, J.; Tai, B. C.; Lee, Y. J.; Park, J.; Kim, J-W.; Kim, B-G.; Tan, D. S.
err分享
err收藏
Trastuzumab deruxtecan (T-DXd) for pretreated patients (pts) with HER2-expressing solid tumors: Primary analysis from the DESTINY-PanTumor02 (DP-02) study
err2023-11-01
err1
PREAI
errOh, D-Y.; Meric-Bernstam, F.; Makker, V.; Oaknin, A.; Banerjee, S.; Gonzalez Martin, A.; Jung, K. H.; Lugowska, I.; Manso, L. M.; Manzano, A.; Melichar, B.; Siena, S.; Stroyakovskiy, D.; Fielding, A.; Ma, Y.; Puvvada, S. D.; Lee, J-Y.
err分享
err收藏
InnovaTV 301/ENGOT-cx12/GOG-3057: A global, randomized, open-label, phase III study of tisotumab vedotin vs investigator's choice of chemotherapy in 2L or 3L recurrent or metastatic cervical cancer
err2023-11-01
err3
PREAI
errFujiwara, K.; Slomovitz, B. M.; Gonzalez Martin, A.; Kalbacher, E.; Bagameri, A.; Ghamande, S.; Lee, J-Y.; Banerjee, S.; Maluf, F. C.; Lorusso, D.; Yonemori, K.; van Nieuwenhuysen, E.; Manso Sanchez, L. M.; Woelber, L.; Westermann, A. M.; Covens, A.; Whalley, E.; Teng, M. S. L.; Soumaoro, I.; Vergote, I. B.
err分享
err收藏
A phase III randomized controlled trial in primary stage three and four ovarian cancer after interval cytoreductive surgery (FOCUS/KOV-HIPEC-04)
err2023-11-01
err0
PREAI
errLim, M. C.; Kim, J. H.; Park, B.; Park, J-Y.; Lee, J-Y.; Chang, S-J.; Lee, Y-Y.; Hong, D. G.; Park, S-Y.
err分享
err收藏
AdvanTIG-202: Phase II randomized, multicenter, open-label study of tislelizumab (TIS) with or without ociperlimab (OCI) in patients (pts) with previously treated recurrent/metastatic (R/M) cervical cancer (CC)
err2023-10-01
err6
PREAI
errLee, J-Y.; Wu, L.; Boonyapipat, S.; Kim, H. S.; Lee, J-W.; Wang, L.; Wang, T.; Wang, D.; Yao, D.; Liu, H.; Andabekov, T.; Zhang, X.; Wang, W.; Kim, Y. M.; Wang, K.; Gao, Y.; Mu, X.; Sinielnikov, I. Volodymyrovych
err分享
err收藏
First results from the ENGOT-GYN2/ GOG-3051/BOUQUET phase II biomarker-directed platform study: Cobimetinib (cobi) or atezolizumab (atezo) plus bevacizumab (bev) for persistent/recurrent rare epithelial ovarian cancer (eOC)
err2023-10-01
err4
errOAAI
errRay-Coquard, I. L.; Pignata, S.; Lee, J-Y.; Coleman, R. L.; Brown, J.; Kim, J-W.; Selle, F.; Lorusso, D.; Bermejo-Perez, M. J.; Pautier, P.; Gourley, C.; Ayhan, A.; Richardson, G.; Cibula, D.; Yauch, L.; Dieterich, M.; Krishnan, V.; Calas-Zeroug, O.; Harter, P.; Gershenson, D. M.
err分享
err收藏
Durvalumab (durva) plus carboplatin/paclitaxel (CP) followed by maintenance (mtx) durva ± olaparib (ola) as a first-line (1L) treatment for newly diagnosed advanced or recurrent endometrial cancer (EC): Results from the phase III DUO-E/GOG-3041/ENGOT-EN10 trial
err2023-10-01
err6
errOAAI
errWestin, S. N.; Moore, K. N.; Chon, H. S.; Lee, J. Y.; Pepin, J. Thomes; Sundborg, M.; De la Garza, J.; Nishio, S.; Wang, K.; Mcintyre, K.; Tillmanns, T.; Mejia, F. Contreras; De Melo, A. C.; Klasa-Mazurkiewicz, D.; Papadimitriou, C. A.; Martin, M. Gil; Brasiuniene, B.; Donnelly, C.; Liu, X.; Van Nieuwenhuysen, E.
err分享
err收藏
Transcription factor RORα enforces stability of the Th17 cell effector program by binding to a Rorc cis-regulatory element
errIMMUNITY
IF26.3
err2022-11-01
err31
errOAAI
errHall, Jason A.; Pokrovskii, Maria; Kroehling, Lina; Kim, Bo-Ram; Kim, Seung Yong; Wu, Lin; Lee, June-Yong; Littman, Dan R.
err分享
err收藏
Evaluation of blood tumor mutation burden for efficacy of second-line atezolizumab treatment in non-small cell lung cancer: BUDDY
err2022-09-01
err0
errOAAI
errPark, C-K.; Jun, H. R.; Oh, H-J.; Lee, J-Y.; Cho, H.; Kim, Y-C.; Lee, J. E.; Yoon, S. H.; Choi, C. M.; Lee, J. C.; Lee, S. Y.; Lee, S. Y.; Chun, S-M.; Oh, I-J.
err分享
err收藏